Catalyst Wire Dossier Catalyst Wire Dossier

Gel Stent (XEN63)

· AbbVie
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gel Stent (XEN63), covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma [Phase 3]

See pricing